The Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jan 29, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The investigators propose to carry out three Specific Aims:
1. Determine whether markers of ovarian age/aging are associated with increased CVD risk.
Specifically, the investigators propose to assess whether:
1. Ovarian age predicts CVD risk (measured by peripheral endothelial function testing) independent of chronological age.
2. The rate of ovarian aging is independently associated with increased CVD risk after adjustment for ovarian and chronological age.
2. Determine whether ovarian aging may moderate or mediate established associations between race/ethnicity and CVD risk and...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Enrollment into the original OVA cohort (NCT00501800)
- Exclusion Criteria:
- • Not a member of the original OVA cohort
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Marcelle I Cedars, MD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials